In this week’s Video Forum, Joe DePinto, head of cell, gene and advanced therapies at McKesson, talks about the company’s new InspiroGene division and the impact it is expected to have on the biotech marketplace. Precision dispensing and patient management, the product pipeline for advanced therapies, and recent research from InspiroGene were among the topics discussed.
Video Forum: Joe DePinto, McKesson
New division takes aim at cell and gene therapies.
Related
Coffee Chat: Pascal Houdayer, Boiron
Boiron’s CEO on integrative Health, homeopathy and the future of holistic care.
Coffee Chat: David Pope, XiFin
David Pope is the Chief Pharmacy Officer at XiFin, a healthcare information technology company.
Latest
Save Mart, Lucky launch ‘WIN-WIN Event’ with $250,000 grand prize
?We’re thrilled to bring our shoppers a program where every ticket wins.?
FMI, experts warn tariffs could pressure food prices despite strong consumer sentiment
Grocers operate on profit margins of just 1.7%, leaving little room to absorb higher costs.
Cool Sips x poppi debut limited-edition dirty sodas
The partnership marks Cool Sips’ first collaboration with a national brand since launching in 2024, underscoring its rapid growth in the competitive beverage market.
Resonate: Consumers mostly unmoved by tariffs but willing to cut back if necessary
Holiday spending is also set to soften: 38% more consumers are opting out of gift buying compared to two years ago, and 25% plan to shop only during major sales events.